Filing Details
- Accession Number:
- 0001104659-21-110764
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-30 09:11:15
- Reporting Period:
- 2021-08-27
- Accepted Time:
- 2021-08-30 09:11:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1772028 | Scopus Biopharma Inc. | SCPS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1449211 | Scott Ira Greenspan | C/O Scopus Biopharma Inc. 420 Lexington Avenue, Suite 300 New York NY 10170 | Executive Committee Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2021-08-27 | 110 | $4.92 | 82,450 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.001 | Acquisiton | 2021-08-27 | 790 | $4.98 | 14,640 | No | 4 | P | Indirect | HCFP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | HCFP |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.91 to $5.00 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.96 to $5.00 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
- Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein.
Billionaire Hedge Funds
